glp-1 obesity drug market size 2025 Drugs to Hit USD 132.79 Bn by 2035 GLP-1 Receptor Agonist Market Growth
Description
Estrogen has pleotropic, beneficial effects on metabolism yet the reproductive endocrine toxicity and tumorigenic potential limits its use in chronic settings other than hormone replacement therapy
In the results of a cohort study published in BMJ, new users of GLP-1 receptor agonists had a 30% lower risk of severe COPD exacerbation compared to new sulfonylurea users
This section discusses general scientific concepts and does not constitute an endorsement of any specific product or clinical claim
Dehydration. Cleveland Clinic , 21 Aug
Beinaglutide alone improves blood glucose management
